In the early 1990s the Canadian Task Force on Preventive Health Care issued a grade B recommendation for counselling perimenopausal women regarding the use of estrogen replacement therapy (ERT) for the primary prevention of osteoporotic fractures.[1][1] At that time, the large observational studies
No takes yet. Share an insight, caveat, or question.
C. Nadine Wathen (2004) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: